Yki-Järvinen H - Search Results

1

Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease.

Luukkonen PK, Qadri S, Ahlholm N, Porthan K, Männistö V, Sammalkorpi H, Penttilä AK, Hakkarainen A, Lehtimäki TE, Gaggini M, Gastaldelli A, Ala-Korpela M, Orho-Melander M, Arola J, Juuti A, Pihlajamäki J, Hodson L, Yki-Järvinen H. Luukkonen PK, et al. J Hepatol. 2022 Mar;76(3):526-535. doi: 10.1016/j.jhep.2021.10.013. Epub 2021 Oct 25. J Hepatol. 2022. PMID: 34710482 Free PMC article.

2

The fatty liver and insulin resistance.

Yki-Järvinen H, Westerbacka J. Yki-Järvinen H, et al. Curr Mol Med. 2005 May;5(3):287-95. doi: 10.2174/1566524053766031. Curr Mol Med. 2005. PMID: 15892648 Review.

3

Fat in the liver and insulin resistance.

Yki-Järvinen H. Yki-Järvinen H. Ann Med. 2005;37(5):347-56. doi: 10.1080/07853890510037383. Ann Med. 2005. PMID: 16179270 Review.

4

Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes.

Juurinen L, Tiikkainen M, Häkkinen AM, Hakkarainen A, Yki-Järvinen H. Juurinen L, et al. Am J Physiol Endocrinol Metab. 2007 Mar;292(3):E829-35. doi: 10.1152/ajpendo.00133.2006. Epub 2006 Nov 7. Am J Physiol Endocrinol Metab. 2007. PMID: 17090752 Free article. Clinical Trial.

5

Fatty liver: a novel component of the metabolic syndrome.

Kotronen A, Yki-Järvinen H. Kotronen A, et al. Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):27-38. doi: 10.1161/ATVBAHA.107.147538. Epub 2007 Aug 9. Arterioscler Thromb Vasc Biol. 2008. PMID: 17690317 Review.

6

Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects.

Kotronen A, Juurinen L, Hakkarainen A, Westerbacka J, Cornér A, Bergholm R, Yki-Järvinen H. Kotronen A, et al. Diabetes Care. 2008 Jan;31(1):165-9. doi: 10.2337/dc07-1463. Epub 2007 Oct 12. Diabetes Care. 2008. PMID: 17934148

7

Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver.

Kotronen A, Seppänen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, Ruskeepää AL, Oresic M, Yki-Järvinen H. Kotronen A, et al. Diabetes. 2009 Jan;58(1):203-8. doi: 10.2337/db08-1074. Epub 2008 Oct 24. Diabetes. 2009. PMID: 18952834 Free PMC article.

8

Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts.

Kotronen A, Yki-Järvinen H, Aminoff A, Bergholm R, Pietiläinen KH, Westerbacka J, Talmud PJ, Humphries SE, Hamsten A, Isomaa B, Groop L, Orho-Melander M, Ehrenborg E, Fisher RM. Kotronen A, et al. Eur J Endocrinol. 2009 Apr;160(4):593-602. doi: 10.1530/EJE-08-0900. Epub 2009 Feb 10. Eur J Endocrinol. 2009. PMID: 19208777

9

A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans.

Kotronen A, Johansson LE, Johansson LM, Roos C, Westerbacka J, Hamsten A, Bergholm R, Arkkila P, Arola J, Kiviluoto T, Fisher RM, Ehrenborg E, Orho-Melander M, Ridderstråle M, Groop L, Yki-Järvinen H. Kotronen A, et al. Diabetologia. 2009 Jun;52(6):1056-60. doi: 10.1007/s00125-009-1285-z. Epub 2009 Feb 18. Diabetologia. 2009. PMID: 19224197 Free article.

10

Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins.

Makkonen J, Pietiläinen KH, Rissanen A, Kaprio J, Yki-Järvinen H. Makkonen J, et al. J Hepatol. 2009 May;50(5):1035-42. doi: 10.1016/j.jhep.2008.12.025. Epub 2009 Feb 18. J Hepatol. 2009. PMID: 19303161

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

463 results

Search Page